Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 2 |
2009 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
Anticancer Res. 2006 May-Jun;26(3A):1869-76.
Anticancer Res. 2006.
PMID: 16827119
Free article.
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent.
Vaziri SA, Grabowski DR, Hill J, Rybicki LR, Burk R, Bukowski RM, Ganapathi MK, Ganapathi R.
Vaziri SA, et al. Among authors: rybicki lr.
Anticancer Res. 2009 Aug;29(8):2961-9.
Anticancer Res. 2009.
PMID: 19661301
Free PMC article.
Item in Clipboard
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
Chikamori K, Hill JE, Grabowski DR, Zarkhin E, Grozav AG, Vaziri SA, Wang J, Gudkov AV, Rybicki LR, Bukowski RM, Yen A, Tanimoto M, Ganapathi MK, Ganapathi R.
Chikamori K, et al. Among authors: rybicki lr.
Leukemia. 2006 Oct;20(10):1809-18. doi: 10.1038/sj.leu.2404351. Epub 2006 Aug 17.
Leukemia. 2006.
PMID: 16932348
Item in Clipboard
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin.
Vaziri SA, Hill J, Chikamori K, Grabowski DR, Takigawa N, Chawla-Sarkar M, Rybicki LR, Gudkov AV, Mekhail T, Bukowski RM, Ganapathi MK, Ganapathi R.
Vaziri SA, et al. Among authors: rybicki lr.
Mol Cancer Ther. 2005 Dec;4(12):1880-90. doi: 10.1158/1535-7163.MCT-05-0222.
Mol Cancer Ther. 2005.
PMID: 16373703
Item in Clipboard
Cite
Cite